Description: In an effort to scale the amount of quality, long-form research for the community, we are proposing Enzyme commissions an initiation of coverage report through Messari’s Protocol Services. This would provide a comprehensive overview of Enzyme and how it fits into the web3 asset management landscape and DeFi more generally. The report will touch on major KPIs and fundamental usage metrics while also discussing the token mechanics and how value flows through the system. Examples include:

• Osmosis
• Yearn
• Injective

These reports would live as free resources on Messari and would be distributed through our newsletter (230k subscribers) and various social channels. We would then host a webinar with the writing analyst and a member of Avantgarde to discuss the report in detail and engage the community with Q+A.

Benefits: The benefit of the report would be increased knowledge and awareness of Enzyme for the larger crypto community. The exposure Enzyme would receive through this report would help attract more users, developers, and investors who are more likely to allocate time and money to provide value to the overall network after being more aware of the material developments going on. This could include more protocols looking to integrate Enzyme for their treasury management solutions, asset allocators interested in spinning up their own fund, or investors seeking to put capital in alternative vehicles.

Timeline:
The report would be released the first week in September

Funding: $35,000
Annual Protocol Services membership (2 years): $15k
Initiation of coverage report: $15k
Analyst call: $5k

Contact Information:
Jack Purdy, Business Development Lead for Messari Protocol Services
Email: [email protected]
Telegram: @JackPurdy

• Proposal

  • Add support for PoolTogether protocol, allowing vaults to mint and redeem ticket tokens, thus providing depositors exposure to crypto-powered premium bonds

• Motivation

  • https://enzyme.canny.io/feature-requests/p/pooltogether-support
  • TVL PoolTogether $200m
    • https://defillama.com/protocol/pooltogether
  • Yearn finance vaults are using PoolTogether with some of their strategies
    • https://medium.com/yearn-state-of-the-vaults/the-vaults-at-yearn-9237905ffed3
  • Current gas costs prevent individuals from entering pools, making it compelling to do it from an Enzyme vault: splitting gas cost, farming POOL and increasing odds of winning
  • similarity with existing Aave and Compound integration
  • got the idea of submitting this proposal during the last Enzyme community call
    • 

• Implementation

  • why me?
    • ex CTO of multis.co (crypto wallet for companies, eFounders, Y Combinator S19)
      • https://multis.co/
    • fullstack engineer from Solidity to CSS with 10 year experience
      • https://www.linkedin.com/in/teawaterwire/
    • deep knowledge of DeFi protocols
      • Degen score pending ;p
    • user and evangelist of PoolTogether since v1 (now v3)
      • https://twitter.com/teawaterwire/status/1232794151495897090
    • active user of Enzyme through the fund "La Crypto C'est Rigolo"
      • https://teawaterwire.medium.com/la-crypto-cest-rigolo-d3e8f224044a
  • code wise
    • i already looked into other adapters to see what would be needed in terms of development:
      1. PoolTogetherFeed.sol
         • PoolTogether ticket tokens are pegged 1:1 to the base asset (DAI, USDC etc)
         • making them fall in the "derivatives" category
         • and it will be similar to Aave aTokens in this regard
      2. IPoolTogetherPrizePool.sol
         • exposing methods of PoolTogether prize pools
      3. PoolTogetherAdapter.sol
         • using contracts from a. and b.
         • falling into the Yield category we would implement the "lend" and "redeem" method
           • lend would be the "minting" of ticket tokens from any of the base assets supported by both PoolTogether and Enzyme
             • all parameters of this method are straightforward
             • only question remains regarding the "referrer" reward. i'd suggest it goes either to the fund manager or to Enzyme.
           • redeem would be the "withdrawing" of previously minted ticket tokens.
             • one ticket token converts one to one to the base token
             • only caveat is around the "maximumExitFee" parameter: all pools have an "earlyExitFee" to enforce fairness. This will require some work on the frontend to warn and prevent managers to withdraw too early
  • other considerations:
    • NFT:
      • Prize pools can award NFTs with the loot box. At the moment NFTs are not supported by vaults, but since they are not the main feature of PoolTogether (as opposed to the pooled reward from yield) we can just ignore them at the moment
    • POOL tokens:
      • PoolTogether introduced a governance token POOL à la COMP
      • by entering incentivised pools, ticket holders are farming POOL tokens
      • anyone can claim tokens accumulated by an address
      • i suggest here the implementation in the Rewards section of Enzyme to allow fund manager to withdraw rewards
      • POOL needs to be added to the supported assets in Enzyme. I believe PoolTogether team will be glad to sponsor the Chainlink price feed for that matter.

• Compensation

  • i estimate between 5 and 10 days to deliver a complete solution, tested, and integrated with the frontend
  • depending on the necessary audit on the new contracts, more back and forth could be required
  • i suggest invoicing on a half day basis for around $300
  • payment with MLN tokens converted at the time of the transaction (when pull request is accepted) would be cool

DESCRIPTION:

We at humanDAO are excited to present this strategic partnership with Enzyme through the creation and maintenance of a custom AI Assistant, designed to meet Enzyme Finance's specific needs. This AI Assistant aims to simplify developer onboarding, expedite asset management strategies, and offer comprehensive protocol and community information for users and investors.

Our primary objective is to elevate the total value locked (TVL) within the Enzyme protocol by drastically simplifying the learning curve — making Enzyme more user-friendly and streamlining the due diligence process.

We are also pleased to share that our demo bot for Enzyme, currently operating at roughly 75% performance, is ready for trial. The system works with a closed loop database of enzyme specific information, that we curate ourselves. This optimizes the reliability of the answers and reduces the chance of hallucinations for the end-user. Should you accept our proposal, we commit to working closely with the Council and Avantgarde, utilizing user feedback to elevate the bot's performance to 99%.

By collaborating with Enzyme Finance, humanDAO aims to create a mutually beneficial relationship, showcasing our advanced AI technology while enhancing the Enzyme Finance ecosystem, fostering growth, and increasing its user base.

USEFUL LINKS:

• AI Assistants Page
• Enzyme Demo Bot
• humanDAO Main Site

BENEFITS TO ENZYME:

AI Assistants, powered by humanDAO, is a unique AI solution engineered to streamline interactions within web3, this one specifically for the Enzyme Finance ecosystem. This solution is designed to enhance and streamline web3 interactions, integrating a vast array of protocol information to make it readily accessible to developers, fund managers, and investors wherever they interact with Enzyme.

Features

Key features of the proposed chatbot include:

• Comprehensive documentation and protocol information for developer onboarding
• Asset management strategy generation with Avantgarde's assistance
• Round-the-clock support for fund managers or users, answering queries about the protocol
• Investor-friendly content that enhances understanding of Enzyme Finance and its use cases
• Multi-language support
• Integration with Telegram, Discord, and websites
• AI Assistants provide sources, images, and links
• Free credits to our Human Task Force (more info below)

The Enzyme AI Assistant leverages advanced AI algorithms to deliver accurate and most importantly, up-to-date information. This Assistant, unlike other solutions, will be trained on a comprehensive dataset, including Enzyme's documentation, to ensure the highest level of proficiency in responding to user inquiries.

The Assistant can also utilize Avantgarde to generate asset management strategies, aiding users in optimizing their returns on the platform. This feature is expected to not only enhance the success rate of users but also attract additional investments to the platform, leading to an increase in the total value locked (TVL).

Branding

Another key aspect of this proposal is the customization of the AI Assistant to align with the Enzyme brand. We understand the importance of maintaining a consistent brand image and user experience. Therefore, we will ensure that the AI Assistant not only functions seamlessly within the Enzyme ecosystem but also embodies the look and feel of Enzyme. This includes aligning the bot's interface design, language style, and interaction patterns with Enzyme's brand.

Human Impact

This proposed partnership between humanDAO and Enzyme Finance holds significant potential to benefit underserved communities. Our Human Task Force plays a crucial role in our AI Assistant endeavors. They continuously validate and update the information and data provided to our AI Assistants. The Human Task Force ensures that users of our AI Assistants will always have the most current and accurate information about new Enzyme features, integrations, and other developments.

Additionally, this proposal encompasses complimentary energy credits for the utilization of our task force once it transitions out of its beta phase. These credits can be leveraged by Avantgarde or the Council to assist in Enzyme-related initiatives. The volume of these free credits equates to the workload of one full-time employee and will remain valid for the duration of this agreement.

By providing a customized AI Assistants, we also aim to democratize access to complex financial information, making it easier for individuals to navigate the Enzyme ecosystem, regardless of their prior knowledge, experience or language barriers. This partnership represents not just a technological collaboration, but also a commitment to financial inclusivity and empowerment.

User Experience

One of the great benefits of our Assistants is their ability to fulfill each stage of the customer journey and adjust their tone and content to the user’s level of knowledge. It’s like marketing, customer service, sales and tech support rolled into one easy to use interface.

TIMELINE:

In good faith we have already started development. If the proposal should pass before June, we believe this estimated timeline to be most accurate.

• (July) finely tune the bot to as close to 99% as possible
• (July) for any Enzyme-related design and branding updates
• (Aug) Telegram and Discord integration

FUNDING:

To actualize this collaboration, we propose the following budget allocation:

1. Development and Integration fee: 15,000 MLN. Half due upon proposal approval, and remainder due when the full timeline objectives have been achieved.
2. Maintenance and Upgrade fees: 1,500 MLN annually (or more, info below)

Development fee

This one-time fee will cover the development, integration, and 1st years maintenance of the Enzyme Assistant. With this investment, Enzyme Finance will acquire a state-of-the-art AI solution that enhances user experience, improves developer onboarding, and contributes to the overall growth of the platform.

Maintenance and Upgrade fees

This fee is yearly and encompasses all the resources and time needed to improve/upgrade systems as well as collect new info/data when relevant. Should Enzyme and the AI Assistant see a surge in popularity, yearly maintenance costs will rise due to the need for additional resources to maintain optimal performance and handle the increased traffic. This justifies a higher fee to cover these costs and ensure continued high-quality service. While exact cost increases are hard to predict, we anticipate that a tenfold (10x) usage increase should not lead to more than a twofold (2x) cost increase. Any fee increases will be substantiated with relevant costs, data, and metrics.

TOKEN USE:

As a Decentralized Autonomous Organization (DAO), any Enzyme tokens we acquire will be securely held in our treasury. They will remain there until a formal vote determines their utilization. We wish to assure Enzyme investors that we currently have no intention of selling these tokens into the open market. Our primary goal is to diversify our treasury holdings and have it increase in value in the next bull market.

In closing, Enzyme presently allocates 300,600 tokens annually, specifically dedicated to protocol enhancement and user onboarding. The proposed one-time 15,000 MLN represents less than 5% of this yearly inflation. Furthermore, the maintenance fee constitutes less than 0.5% of the annual allocation, demonstrating the cost-effectiveness of our proposal.

ADDENDUM:

This is a follow-up to the initial proposal and the subsequent insightful feedback we received. We greatly appreciate the constructive thoughts, which have helped us align our objectives to better serve the needs of Enzyme Finance.

To address the three main areas of interest detailed in the feedback, we have segmented the proposal into three distinct phases. This approach allows us to focus on delivering tailored solutions for each domain - customer service automation, activities and strategies analysis, and learning from the broader crypto fund/asset management universe.

Phase One: Customer Service Automation AI Assistant

We propose to concentrate on developing a customer service automation solution. Our AI Assistant will be primarily focused on delivering exceptional customer service, streamlining the onboarding process, and acting as a sales persona to attract and retain users.

Key features include:

• Multi-Language Support: To ensure inclusivity and reach a global user base.
• 24/7, 365 Days Service: To offer consistent, round-the-clock support for all users, irrespective of their timezone.
• Cross-Platform Compatibility: Ensuring accessibility and service across all platforms where Enzyme is present.
• Developer/Tech Query Resolution: Answering technical queries to assist developers and technical users.
• Enhanced User Onboarding: Utilizing AI to simplify the onboarding process, guiding new users step-by-step through creating vaults, connecting wallets, or making their first transactions. By automating these key early interactions, we can make the user experience more enjoyable, less overwhelming, and subsequently increase user retention rates.

Funding Request

With the proposal now being segmented and with implementation of Phase One, we seek 2500 MLN for the full development, integration, future upgrades, and first-year maintenance of the Enzyme AI Assistant for customer service automation.

Yearly maintenance will also be reduced to 250 MLN per year.

CONFLICTS OF INTEREST: the author is the founder/builder of humanDAO as well as an Enzyme Council member. This proposal was published by his account and due to this conflict will refrain from voting on this MFP proposal.

CONTACT INFO

[email protected]

Twitter

Following the initial term, the advisor has initiated and developed a number of work programmes around strategic ventures, financial reporting, developing the refreshed grant programme, token mechanics, governance and other transaction related opportunities. The ask is to extend the contract for a further 4 months until December 31 to continue working on the above initiatives. The fee is 2,775 MLN with a bonus of 2,775 MLN should certain objectives be met as discussed in Enzyme Council.

Abstract
This EFP proposes that Avantgarde Core continue to lead the development of the Enzyme Protocol over the next three years, from October 2022 to September 2025.

Background
In March 2019, Enzyme v1 was released and the protocol was decentralized. Several months on, there were were close to zero users. The project was failing because the protocol was very difficult to use and other than trading with DEX’s it was not compatible with other DeFi protocols that had come out by then (eg. Compound, AAVE, etc). With the token price at around $3, few people were willing to build on Enzyme and those that were, were dumping the token quickly to raise funds in a bear market putting additional pressure on the situation. As a result of a depressed token price, the available pool of incentives for builders was incredibly low due to the token price.

Avantgarde Core intervened in Q3 2019, making a proposal to underwrite the cost of development independently over the three years that followed and laid out a roadmap addressing many of the problems the protocol was facing. We applied for a grant of 180,000 MLN/year for three years. At the time, that was worth < $1.5m. Furthermore, we understood the importance of aligning interests and not dumping the tokens on the market to further aggravate the problem. We agreed to accept 75% on a vesting schedule of 2-5 years. The remaining 25% were paid to us quarterly with no vesting conditions, though we have never sold any on the open market.

Needless to say, we were well aware at the time that the actual cost of continuing to grow and maintain a protocol like Enzyme would cost us multiples more than $500,000 / year. However, we were able to work with this budget because of some very high financial risks and sacrifices that a small group of devoted people made at that time. Our motivation was driven by our long-term conviction that if we succeeded, MLN would eventually be worth much more.

The Council supported our proposal at the time. The last 2.5 years has been spent executing on it and transforming Enzyme into a material platform with hundreds of asset managers and thousands of users. AUM kept making new highs for several months after the markets peaked reaching a high of around $230m. Maintaining a degree of roadmap flexibility was a critical part of contributing towards the protocol’s success over the last 2.5 years and has enabled us to be nimble and adapt the roadmap quickly according to new use-cases, market developments and trends.

Some highlights include:

Development achievements, features & integrations

• Three major releases v2, v3 and v4 in the space of 28 months.
• Integrations with some of the biggest and most widely used protocols in DeFi
• DEX’s: Paraswap, 0x, Kyber, Curve, Uniswap v2, Uniswap v3 & Synthetix.
• DeFi: Lending and borrowing on AAVE & Compound, Uniswap v2 pools, Uniswap v3 pools, Curve pools, ability to deposit curve pool LP tokens to Convex staking contracts Convex voting, Idle strategies, Yearn strategies and more.
• A sophisticated set of subgraphs that track all the data being emitted from events on each set of vault smart contracts and enables us to provide an auditable history of events to our users. Over the last two years the subgraphs have been substantially refactored in order to scale faster and perform higher.
• Maintenance and huge improvements to the entire tech-stack behind our app as well as its performance.
• A complete UX/UI overhaul with continuous improvements to cope with the added complexity.
• Helping coordinate activity with each bug bounty and improve processes and transparency with the Enzyme Technical Council.

L1 & L2 research and plans

• Researched and deployed Enzyme and surrounding tech-stack on Polygon.
• Continue to explore other L1 & L2 plans with focus on growth possibilities.

Growth and usage

• More than 1500 vaults
• More than 3500 investors
• Normalized AUM growth in ETH terms exceeding peers (below data is after Celsius redemption)
• More in depth report of marketing activities and results available here

As our grant period of three years is coming to an end, we’d like to thank the Enzyme Council and the broader community for trusting us to lead development in this role and propose a renewal of contract for the next three years starting in October 2022.

Motivation
We believe we’ve accomplished a lot and we feel that there is still a lot we can do for Enzyme to reach its full potential as the DeFi operating system. We have spent the last few years building what we strongly believe is the basis for many different use cases in asset management. We believe these will underpin the future of DeFi asset management.

Our learnings and current velocity drives our motivation to continue working on Enzyme. We believe that the protocol is uniquely positioned for the following reasons:

• It is the only asset management platform that has evolved and grown in a material way over the last few years.
• It is now at a point where it is harder to compete with Enzyme as an asset management platform in DeFi given its 3.5 year on-chain reputation for reliability, surviving a bear market, the work on integrations, meaningful features and generating momentum that is hard for others to now replicate from scratch.
• We have identified target user markets and new use cases where we are gaining traction.
• DAO treasury (FWB DAO, HumanDAO and others in the pipeline)
• Cross-chain liquidity with Celsius (*note since recent events unfolded this use-case has been unwound until further notice)
• Collateral management for insurance DAOs (eg. Unslashed)
• We’re planning to scale up activities related to education and sales to increase the speed at which users decide to open an Enzyme vault and deposit funds

Continuous improvement & implementation

As we’ve learnt in the past, laying out a long term roadmap which is not flexible in nature is difficult in such a fast changing environment as DeFi. What we have found works well is presenting quarterly updates to the Council on what we will be working on and then reporting progress back at the end of each quarter. This enables us to be nimble, agile and react quickly to changing business development priorities that we other stakeholders identify.

However, some of the items this grant proposes to cover are as follows:

• Continuing to fund the core Enzyme team of what now consists of 14 developers,1 Project Manager, 1 Product Manager, 1 Biz Dev, 1 Operations and 1 UX/UI designer.
• Creating and maintaining a user-centric roadmap where new features and potential architectures are researched and prioritized based on the AUM they can bring to the Enzyme protocol and tied to concrete business outcomes
• Researching and implementing new major release(s) based on user feedback over the course of the next three years. These release(s) will include features prioritized and driven by direct input from the business dev team and should link to concrete AUM growth opportunities
• Deploying to other non-Ethereum networks (added to the roadmap with the same focus on potential AUM growth and concrete business outcomes)
• Continuing to maintain a front-end for all releases
• Filtering and addressing bug reports, managing Immunefi inflow of reports, user trouble-shooting and maintenance for integrations upon upgrades/3rd party bugs, etc
• Community management across all public channels (helping maintain the community Telegram, Discord, Twitter etc)
• Making Enzyme visible in a governance capacity by actively participating in other DeFi governance conversations and proposals in a way that benefits Enzyme.
• Managing a marketing strategy and growing our current efforts such that they are on par with our peers
• Maintaining financials and publishing quarterly Council reports to improve transparency.
• Improving documentation for 3rd-party developers and SDK tooling for plug-in managers.
• Facilitating the Enzyme Council to operate independently in the future utilizing SOP’s, DAO tooling etc.
• Integrations to make Enzyme more visible and composable (eg. building out API for Etherscan, Cryptocompare, Metamask), negotiating custody agreements for vault tokens, wallet partnerships, helping other teams build on Enzyme, etc
• Proposing a new framework for asset universe maintenance
• Note that we have not included 3rd party protocol integrations in this quote but we will work on that outside of the scope of this proposal.

Funding Requirements

Part I
Given the appreciation in the MLN price since the last time we brought forward a proposal, we propose reducing our ask from 180k to 90k MLN/ year + 100,000 USDC paid in four installments at the end of each quarter of 22.5k MLN + 25,000 USDC per quarter, based on today’s 90day VWAP price of $32.4. *Note today’s date at time of writing is July 5th, 2022.

In order to protect the robustness of our contribution during a downward move in the market, we would like the option to adjust this amount to 30k MLN/quarter if 90 day VWAP drops below $30, and 40k MLN/quarter if 90 day VWAP drops below $20 for those respective quarters.

To align interests we propose that 60% of the tokens are granted to us in liquid form and paid quarterly, and 40% are vested and split into quarterly payments, each payment vesting over 2 years.

We’ve modeled a few scenarios on what this total compensation package would look like. Note that for simplicity we show the total amount of MLN but in reality a large portion of these tokens would be vested over 2 years. Once again Avantgarde will have to take some market risk because of the vesting nature of this proposal but commits to underwriting this period as long as still engaged by the council.

Reference: https://docs.google.com/spreadsheets/d/1xfTNkT8nR67AsqtmuASruYR22VM1aUeM7KgbfXy7tj0/edit#gid=0

Part II
We would like to propose a variable component to the funding which is directly linked to growing AUM in order to incentivize our marketing, business development and sales efforts as we build those out further.

The idea behind this part of the compensation is:

• Incentivizing the team with upside on their AUM growth (measured in ETH terms) as well as development
• More closely linking and aligning Avantgarde performance with Enzyme success
• Deriving a model which is reusable with other 3rd parties and will help us scale Enzyme usa-cases and AUM

The council has shown interest in rolling out a referral program in the past. We propose formalizing this program so that ourselves and others can participate in it. We are happy to initiate and moderate the discussion around this.

Milestones & Check-ins
We propose to continue the regular informal check-ins with the council at the bi-weekly council meetings and to keep the council aware of changing priorities and work being implemented. We also propose more formal quarterly updates on progress and proposed roadmap for the subsequent quarter presented in writing.
The council (which is also composed of user-representatives) can always challenge and reject our suggestions if they feel there is something more pressing. We will do our best to accommodate these feature requests in a timely manner.

Team
Most of the work is outsourced contractually to the Avantgarde Finance whose team can be found here https://avantgarde.finance/company

Contact information:
For more information please contact [email protected]

Grant Request: Secure an additional 6 months funding for Enzyme PR campaign

⚡️ Executive summary

As the digital economy continues to evolve, so does the need for strategic and targeted public relations. Antidote Communications, in partnership with Enzyme, has already achieved significant progress in enhancing reputation and increasing performance within the innovative asset management and finance sector. To continue building on these successes, an additional 6-months of funding is required. The following proposal outlines the performance metrics, results achieved, and new objectives and strategies for the next phase of collaboration.

Please click here to view an in-depth review of performance to date, as well as strategic ideas for the upcoming 6 months.

💡 How do we measure performance?

Measuring performance is integral to our success. We focus on:

1. Media Coverage: Analysing the number, reach, and quality of publications and interviews.
2. Alignment with Goals: Regularly reviewing our strategies and tactics to ensure alignment with Avantgarde's commercial goals.
3. ROI Metrics: Monitoring the return on investment through business performance indicators.
4. Google Analytics: We have recently launched a new Avantgarde website and will now be able to track in-depth analytics for web visitors tied to our PR campaigns.
5. Social Media: Analyse our social media presence, particularly around the launch of press releases and newsworthy articles, to assess an uplift in engagement.

🚀 Results so far

The partnership between Antidote Communications and Enzyme has yielded significant successes, including:

• 73 pieces of media coverage secured in high-profile publications like City AM, CoinDesk, The Defiant, Global Investor, Professional Investor, Forbes, and others.
• Interviews with esteemed platforms such as Bloomberg, CoinDesk, Risk.net
• Through strategic PR activities, we've enhanced Enzyme’s visibility in the DeFi, finance and asset management sectors

📈 Objectives and strategy

To continue the momentum, the following objectives and strategies will be pursued in the next 6 months:

1. Promote Asset Management Thought Leadership: Leveraging Ainsley To, Head of Asset Management at Avantgarde, we will showcase our expertise and insights in asset management.

2. Broaden Financial Sector Communication: To open up additional opportunities in large Traditional Finance (TradFi) publications.

3. Run a Survey of Institutional Investors: We will conduct a comprehensive survey of institutional investors and analyse the results. The insights drawn from this survey will be used to create a press release for additional coverage, providing valuable data to the investment community and enhancing our thought leadership profile.

4. Joint Thought Leadership Initiatives: Collaboration with clients or warm contacts such as Brevan Howard, Signup, CiTi Bank, etc., will allow us to create co-authored thought pieces and shared insights that further our influence in the market and solidify partnerships.

5. Book Additional Interviews and Podcasts: By securing more interviews and podcasts, we can open the door for further collaboration, increase visibility, and reinforce our position as thought leaders in the field.

The new objectives and strategies reflect a comprehensive and multifaceted approach that builds on our existing success and aims for sustained growth and engagement in the evolving financial landscape.

💰 Funding Request

To continue our successful partnership with Antidote Communications, we are seeking additional funding for the next 6 months of PR activities. The detailed calculations for the funding request are as follows:

- Antidote's Monthly Retainer: £5880
- Current Exchange Rate: 1 GBP = $1.27 USD
- Monthly Cost in USD: £5880 * $1.27 = $7,465
- Total Cost for 6 Months: $7,465 * 6 = $44,790

We are therefore requesting a total of $44,790 in MLN tokens to fund the continued PR activities. This investment will enable us to pursue our new objectives and strategies, ensuring that we maintain momentum in promoting our asset management thought leadership, engaging with the financial sector, and securing additional media coverage.

We believe that this funding will provide valuable support to our ongoing efforts, driving growth and collaboration in line with our strategic goals.

🤝 Conclusion

The initial results from our collaboration with Antidote Communications demonstrate success and alignment with Enzyme’s goals. The proposed extension will allow us to delve deeper into key areas of interest and further our position in the market. We believe that with the additional 6 months of PR activities, we can continue to build on our success and contribute to the growth and innovation of the financial sector.

By granting this proposal, the Enzyme Council will be supporting a proven partnership, enabling Enzyme to lead in the intersection of technology, finance, and innovation.

Thanks,

Conor Gilmore
Head of Marketing at Avantgarde

Email: [email protected]
Telegram/Twitter: @TheKidCG

Shaman Trading is sharing its funding proposal with Enzyme. We are confident that our proposal is in alignment with the next big narrative in Crypto the unimaginable growth of tokenized Real-World-Assets, and the requirements of Enzyme's Grant program to drive business growth, long-term and sustainable partnership, and added-value and utility creation for shareholders.

We express our gratitude to the Enzyme Council DAO for considering our proposal.

Shaman Trading ENZYME Funding Proposal v2 (2).pdf

Contact
Harry Sidi
[email protected]
TG: sidi25

r3gen Finance is proud to present an offering to provide accounting and financial reporting services to Enzyme. We aim to deliver exceptional value to the Enzyme council by providing you with accurate and insightful data that will serve as a strong foundation for more informed decision making and improved strategic planning.

Who are r3gen?

At r3gen Finance, we offer a unique combination of deep crypto-expertise and extensive experience gained from working at 'Big Four' professional services firms. This allows us to provide high-impact, cost-effective support to our clients. Our team has experience working with some of the largest names in Web3; Index Coop, Gitcoin, Aave, Treasure and Squid.

Working with us Enzyme gains access to a team of experts with a broad range of experience across various business areas that will help Enzyme thrive in a rapidly evolving industry.

What will Enzyme get?

Bookkeeping

• Bookkeeping since genesis of on-chain & off-chain transactions.
• Bookkeeping of on-chain & off-chain transactions in June, July and August 2023.

Reporting

• Historic annual financial statements 2019-present.
• GAAP-compliant management accounts (financial reports) for June, July and August 2023.
• DAO Credit Card
• Mesha multi-sig linked DAO Corporate Card to aid with off-chain subscription & expense management.

What does it cost?

Bookkeeping

• $4,200 + $1,200 web3 accounting stack licence

Reporting

• $7,600

DAO Credit Card

• Free of Charge

Total cost of engagement (fixed term ending September 8th 2023): $13,000 USD

We see several compelling synergies between Enzyme and r3gen. That’s why we’ve discounted our prices and are taking our full fee in $MLN to reflect our desire to form a long lasting relationship.

We look forward to working with the Enzyme Council and being able to contribute to the success and growth of the organisation.

Background:

The general idea for an Enzyme affiliate/referral program had been lightly brought up and supported in past Enzyme Council discussions (initially by Will Harborne)
It was formalized and discussed with ENZIP 13 (enzymefinance/enzip#13).
Which resulted into MFP 17 (#17) and its passing governance.
The above has led to this current proposal.

Description of the project:

We propose to run a referral program in a 6-month campaign.
After a few iterations and discussions with the team, the design chosen is as follows:

• Objective: introduce new vault owners to Enzyme
• How: by rewarding existing users for valid referrals
• Terms & Conditions: see "Guidelines & T&Cs" below with details on eligibility, payouts & restrictions, as well as disclaimer

Synergies/benefits to the Enzyme ecosystem

Key benefit: growth in number of vaults on the platform, leading to TVL growth
(item further developed in MFP 17)

Token use

Users initiating valid referrals are eligible for rewards in MLN tokens (T&Cs apply):

• A) an immediate payout (success fee) upon creation of a vault (30 days later)
• B) possibly a bonus payment 6 months later - depending on the vault’s AUM level at that moment

Timeline

The design is ready.
As we opted for a “low-tech” version, the implementation is ready as well.
Upon a successful vote, the program can be launched within a few days.
The program is designed as a 6-month campaign.
As we’ve introduced a cap in the MLN funding for the program, the campaign could also end sooner.

Funding needs

For the 6-month campaign, we propose to set aside a budget of MLN 25,000 (about $500,000 at the average MLN price over the past 6 months)
This figure has been derived from the following parameters & assumptions:

Each successful referral would result in the following outflows (cf. details in T&Cs):
A) immediate rewards between $100 and $200

• amounts based on benchmark for customer acquisition costs and similar programs in fintech

B) a chance to get bonus rewards between $200 up to $1,000

• bonus levels set so that they don’t exceed what the vault would pay as protocol fees within the 6-month period.

We made some rough assumptions as to the number of participants:
10% of users making 2 referrals each, with 50% of referrals eligible for a bonus.

Team presentation

(Same as in MFP17)

• Projet coordinator = osaat
• Project sponsor at the Enzyme technical council = Avantgarde Finance
• Referent person at Avantgarde Tech = Mona El Isa

Contact information

Remarks on the program? please comment below
Other questions about the project? TG: @ oSaaT2

Draft for Guidelines & T&Cs // final version to be released at launch

Guidelines to participate (T&Cs below apply)

You have an organization or a person in mind who should be a vault owner?
It could be someone on the treasury committee of a DAO (or its CFO), a manager looking to launch a fund…
You only need to decide what option suits you best:

1. do you want to send them over to Avantgarde for onboarding (cf. “lite” in T&Cs)?
   → Put us in touch per email with the contact person
   Remember to mention your Enzyme wallet address to get your rewards

2. or you wish to help them create the vault directly (and be eligible for “full” referral)?
   → Let us know per email once the vault is created
   Remember to mention your Enzyme wallet address to get your rewards

Both for the rewards and the later bonus, there are minimum levels of AUM that the vault should reach to be eligible.
Please check the full T&Cs below.

T&Cs:

Disclaimer

• We reserve the right to cancel, modify or terminate the Program at any time for any reasons.

Eligibility

• Referrer:
  • any user of the Enzyme platform (manager or depositor) can become a Referrer
  • the address must have been active on Enzyme up to 30 days prior to program launch
• New vault:
  • to be valid, a Referral must have led within 30 days to a minimum initial AUM of $10k (or equivalent value in tokens)
  • “lite” Referral = user sends a qualifying prospect to Avantgarde; onboarding handled by Avantgarde
  • “full” Referral = vault created directly by new owner, with the eventual assistance of Referrer
  • to be eligible for bonus payment (cf. bonus details below), 6 months after creation, new vault’s AUM must be at least $100k (or equivalent value in tokens)

Restrictions & limitations

• limit of 5 Referrals per user (address) per 30-day period
• program duration of 6 months (or earlier if budget cap is reached)
• global limit of 25,000 MLN allocated to the program

Payout(s)

for a valid Referral (cf. criteria in Eligibility & Restrictions above):

• (A) one-time payout as success fee
  • funds sent to Referrer’s address
  • paid 30 days after vault creation
  • paid in MLN tokens
  • using average MLN price over past 30 days to determine payout amount
  • for “lite Referral”, amount = $100 equivalent
  • for “full Referral”, amount = $200 equivalent
• (B) bonus payment, AUM-based
  • $100k < AUM < $500k ⇒ 100% bonus (of “full Referral”)
  • $500k < AUM < $1m ⇒ 200% bonus (of “full Referral”)
  • AUM > $1m ⇒ 500% bonus (of “full Referral”)
  • AUM < $100k ⇒ no bonus
  • funds sent to Referrer’s address
  • paid 180 days after vault creation
  • paid in MLN tokens
  • using average MLN price over past 30 days to determine payout amount

Other T&Cs

• Program monitoring: under responsibility of Enzyme Council, delegated to a Program manager

Workflow visualized (T&Cs apply)

What we are asking for

Avantgarde is writing to request a grant of $6,000 to sponsor, attend and speak at the upcoming Alternative Investment Managers (AIM) Summit in London on April 13-14, 2023.

We believe that attending this event is an excellent opportunity to showcase the potential of the Enzyme protocol, and to engage with key stakeholders in the traditional finance space that are interested in on-chain asset management opportunities.

We will feature in two sessions at the AIM Summit – see below for further details.

Event 1: Mona El Isa as a speaker on DeFi Panel (2pm on Friday 14th)

Mona will speak on a DeFi panel to an audience of more than 400+ Institutional Investors, Family Offices, Wealth & Fund Managers, Private Investors. The panel topic is still being finalised, but this will give us nice exposure to a wide range of high-profile investors.

Event 2: Avantgarde/Enzyme Roundtable: Building Institutional Grade DeFi Infrastructure for Asset Management (3pm on Friday 14th)

For our second session, we'll host our very own roundtable at the penthouse of the Four Seasons. We will be able to invite 18 delegates for an intimate and informative roundtable, where we'll discuss how investors can access institutional grade DeFi investment opportunities via Avantgarde and Enzyme.

Why should you approve this grant request?

Approving this grant request would allow Avantgarde to showcase the potential of the Enzyme protocol to a high-profile audience of institutional investors, family offices, wealth and fund managers, and private investors. Attending the AIM Summit would also provide an opportunity to engage with key stakeholders in the traditional finance space that are interested in on-chain asset management opportunities. By featuring in two sessions at the event, Avantgarde can position itself as a thought leader in the space, and potentially attract new investors, partners and collaborators to the Enzyme ecosystem.

Here are the benefits that we believe the AIM Summit will offer us.

1. Exposure to potential investors: Attending the AIM Summit provides a valuable opportunity for Avantgarde to showcase the Enzyme protocol to a wide audience of high-profile investors. This exposure could help attract new investors to the Enzyme ecosystem, ultimately contributing to the growth of the protocol.

2. Demonstrating expertise: By speaking at the event and participating in sessions on emerging trends and investment opportunities in DeFi and asset management, Avantgarde can position itself as a thought leader in the space. This can help establish credibility for the Enzyme protocol and attract interest from potential investors.

3. Networking and collaboration: The AIM Summit provides an opportunity for Avantgarde to network with other industry players, including potential collaborators or partners. This could help the Enzyme ecosystem forge valuable relationships that could contribute to the protocol's growth in the long run.

4. Increased visibility and brand awareness: Attending the event and speaking on stage could increase visibility for the Enzyme protocol and raise awareness among a wider audience. This could help attract new users and contributors to the protocol, ultimately contributing to its growth and success.

More info about the AIM Summit

The Alternative Investment Managers (AIM) Summit is an invitation-only event that brings together senior representatives from the alternative investment management industry. The event features keynote speakers, panel discussions, and roundtable sessions on a wide range of topics related to alternative investments, including private equity, real estate, hedge funds, and venture capital. The summit provides a valuable platform for networking, learning, and sharing insights and best practices with other industry professionals. This year's event will take place on April 13-14, 2023, at the Four Seasons Hotel in London.

• 400 + Institutional Investors, Family Offices, Wealth & Fund Managers, Private Investors
• $5 Trillion AUM Represented
• 60 + International Speakers

Costs and sponsorship package

The $6,000 sponsorship fee includes the following deliverables:

• Mona speaking on DeFi panel
• Roundtable event hosted by Avantgarde/Enzyme for 18 pre-determined delegates
• Verbal mention of company name on podium during event and logo on stage
• Mention on website, social media and during the conference
• Access to photos, articles, and other media from the conference for use in social media
• 2 conference pass invitations

Conclusion 💫

In conclusion, attending the AIM Summit presents a valuable opportunity for Avantgarde to showcase the Enzyme protocol to a high-profile audience of institutional investors, family offices, wealth and fund managers, and private investors. Our participation in two sessions at the event will allow us to engage with key stakeholders in the traditional finance space that are interested in on-chain asset management opportunities.

By demonstrating our expertise and sharing insights on emerging trends and investment opportunities in DeFi and asset management, we can position ourselves as a thought leader in the space and potentially attract new investors, partners and collaborators to the Enzyme ecosystem. We believe that attending the AIM Summit is a strategic investment for the growth and success of the Enzyme protocol, and we appreciate your consideration of our grant request.

Thanks,

Conor Gilmore
Marketing Lead at Avantgarde

Email: [email protected]
Telegram/Twitter: @TheKidCG

Description of the project

Hedge3 is a non-custodial, and decentralised DeFi aggregating platform. Designed for investors Hedge3 strives to provide the best investment opportunities for its users, thus our goal is to find and integrate trusted and unique in aggregation market investment mechanisms like Enzyme’s public vaults.

Simplified, Hedge3 is a new and common front-end for several different investment protocols like Yield Farmings, Landings, Asset Management Funds, Indices, and more.

Hedge3 users explore investment opportunities and deposit into contracts using Hedge3 UI, while our intermediary contracts place the user's assets on the appropriate provider’s contracts.

Synergies/benefits to the Enzyme ecosystem

Hedge3 benefit: By listing Enzyme’s publicly traded vaults Hedge3 makes its product more interesting for investors.

Enzyme benefit: Enzyme finance and its publicly traded vaults are getting liquidity from Hedge3 users, Hedge3 directly impacts on AUM growth of Enzyme’s vaults!

We believe Hedge3 and Enzyme have many common interests and looking forward to a long-term partnership.

Needs

Hedge3 is a non-custodial platform that sends all users' deposits directly to its partners. Because of this, Hedge3 makes money through referral fees from the providers.

Hedge3 wants to work with Enzyme and is asking them for a collaboration plan. In this partnership, Enzyme would share a part of the money they make from Hedge3's intermediary contract back with Hedge3.

Meantime Hedge3 asks Enzyme council to approve the Hedge3 intermediary contract to interact with Enzyme’s contracts in order to deposit and withdraw on behalf of Hedge3 users.

It is worth also mentioning that if Enzyme would create an automated referral system and announce it to the market, more aggregators would be interested in integrating with Enzyme public vaults providing additional AUM to them.

The Contract

Github:
https://github.com/hapo92/hedge3-contracts/blob/main/integrations/enzyme/hedge3-enzyme.sol

PolygonScan:
https://polygonscan.com/address/0x94941135333186b91bbAE2353724B3de2811C1A3

Clear timeline

Once the Enzyme Council approves the contract, the Hedge3 MVP can be regarded as complete and ready.

Another month can be spent on platform upgrades, contract audits, and go-to-market preparations.

Team presentation

CEO and one of the co-founders of the project is Jacob Grigoryan, he has 10 years of experience as a web entrepreneur of which 5 years as a co-founder and COO of the web3 software development company Exio Tech.

The CTO and co-founder of Hedge3 is Tatevik Baghdasaryan, she is a PhD in Computer Science specializing in Information Security, she started her career as a network security administrator, then switched to software development where she reached the position of Lead Engineer at Siemens EDA, last couple of years she got inspired by blockchain technologies and wishes to switch to solidity development permanently.

Contact information

GM: grigoryanjacob[@]gmail.com
TG: https://t.me/jacobgrigoryan

Executive Summary
Quidli is a micro on-ramp connecting Web 2.0 apps and web3 assets for you to embed crypto rewards and incentives into your collaboration workflows to boost participation and motivation. The app enables you to recognize your top contributors natively in your Slack and or Discord, and is mainly used today by community managers who want to leverage community engagement on social media. Quidli users include the community teams at ConsenSys, the NEAR Foundation, ETHDenver, OrangeDAO, iExec, Flare Network, Tezos Foundation and CELO.

You can have a look at the Quidli user journey here:
https://www.loom.com/share/419ea488ab3f49d9ab95983638e9fbf2?sid=a3ca18cd-7a37-4e85-92c7-6e1032c0fe87

Proposal:
We propose to you to build a light integration of Enzyme Finance to Quidli by adding MLN to our API and hosted app environment. This will enable you to seamlessly distribute MLN tokens as rewards to the top active participants in your community directly in your Slack or Discord.
In addition to helping you internally share MLN tokens within your ecosystem, this integration lets us offer MLN to our user base of 1000+ organizations as an option via Quidli’s open token platform.

Once completed, $MLN token will be available as an option on:

1. Quidli web app
2. Quidli Slack app
3. Quidli Discord app
4. Any subsequent integrations built by Quidli

Added value for Enzyme Finance:
Through this initial partnership, we’d like to help Enzyme Finance build an awesome community and ecosystem by enabling you to effectively boost community engagement using token incentives. Sharing more tokens with community members can help you to establish a positive alignment flywheel leading to more contributions and ultimately growth towards your main mission and objectives.

Quidli in numbers:
Here’s some key numbers we observed in 2022 on Quidli:

• nb of organizations: 1100+
• transaction volume: ~$2.4m
• nb of transactions: ~140k/month
• Types of orgs: Remote companies, online communities, web3 organizations, DAOs
• Use cases: Recognition, rewards, incentives, ambassador programs

Roadmap proposal:
Define clear Deliverables, Milestones & Timeline

1st Milestone: first week
We review the necessary technical documentation (blockchain, smart contracts, token, etc.). If additional docs and or consultation is needed, we’ll contact you to get connected with the appropriate person/team for guidance.

2nd Milestone: second week
Integration should be in place, and we start testing to ensure the new token is functional and usable within our environment. FYI, we will ask you to send some $MLN in order to perform these initial tests.

3rd Milestone: third week
Review the integration with Enzyme Finance.
Create & publish PR announcing $MLN on Quidli as well as this initial partner with Enzyme Finance.

Timeline: 3 weeks

We’re asking for $5,000 (in $MLN, USDC or fiat preference) to kick off the integration work.

Team:
Justin Ahn - CEO
LinkedIn profile link: https://www.linkedin.com/in/ahnjustin/
Role: Justin is the project coordinator

Guillaume Figielski - CTO
LinkedIn profile link: https://www.linkedin.com/in/guillaume-figielski/
Role: Guillaume oversees token integration and product management

Luke Vignal - Head of Business Dev
LinkedIn profile link: https://www.linkedin.com/in/luke-vignal/
Role: Will be in charge of the partnership coordination and marketing efforts

Titus Decali - UX Designer
Role: Titus will be in charge of the front-end development

Luis Marquez - Back End Dev
Linkedin: https://www.linkedin.com/in/lmarqueze/
Role: Luis will be in charge of the Back-end development

What level of support do you expect throughout the project completion process?
We would like to have support:

• Financial: mainly concerns the integration and research efforts (technical doc) of the dev team and maintenance costs.
• Technical: We review the necessary technical documentation (blockchain, smart contracts, token, etc.). If additional docs and or consultation is needed, we'll contact you to get connected with the appropriate person/team for guidance.
• Marketing: We would like to conduct joint marketing actions in order to promote our community to the MLN token and to introduce the Enzyme Finance community to Quidli as well.

Legal:
Legal Company Name: Quidli Inc
Company Full Address: 16192 Coastal Highway, Lewes, Delaware 19958, USA
Legal Company Identification Number (from incorporation documents): 301130684

Additional ressources:
• Website: https://quid.li/
• Linkedin: https://www.linkedin.com/company/quidli/
• Twitter: https://twitter.com/quidliprotocol
• Medium: https://medium.com/quidli
• GitHub: https://github.com/quidli
• Gitbook: https://github.com/quidli

r3gen Finance is pleased to present an offering to continue providing accounting and financial reporting services to Enzyme, with the addition of financial operations and advisory support. We aim to deliver exceptional value to the Enzyme council by providing you with accurate and insightful data that will serve as a strong foundation for more informed decision making and improved strategic planning, whilst streamlining your financial operations, maximising efficiency and offering financial advice to support protocol development and growth.

Engagement Phase 1 Recap

r3gen have completed their first phase of work with the Enzyme Council Association. The work scope covered bookkeeping and accounting from genesis to date, coupled with the production of historic annual financial statements (y/e 2020, 2021, 2022 and 2023) and monthly management accounts for the months of June, July and August 2023.

In addition to this, a Treasury Insights Report, officially out of scope, has also been generated to highlight specific observations noted during the initial bookkeeping phase. Discussions have also taken place as to how r3gen can support the Enzyme Council with wider financial advisory services relating to protocol development.

Ongoing support

1. Bookkeeping & Reporting
Bookkeeping & Reporting covers the ongoing accounting needs of Enzyme at a cadence that works for you. Ongoing support in this area ensures the Enzyme Council will always have up-to-date information available when it’s needed.

2. Financial Operations & Tooling Optimisation
Financial Operations, whilst essential to running an efficient organisation can be a complex and time consuming process, ultimately distracting team members from building and developing the protocol. Especially in the web3 world, processes such as vendor management, processing payments and payroll are a time consuming process. By outsourcing this you have the peace of mind that rigorous controls frameworks are followed and everything is being tracked, accounted for and reported.

3. Financial Planning & Analysis
Accurate financial information is key to making well informed long-term business decisions. We will provide budgeting, forecasting and runway analysis to lay a solid foundation to such decisions allowing for appropriate resource allocation, expense control and cash flow management.

4. Internal Controls and Best Practices
Ensuring an organisation has sufficient internal controls greatly minimises the risk of loss of funds due to fraud or mistake and when implemented effectively also reduces administrative burden. We will review these important areas, generate a controls report and implement the resulting recommendations, maintaining the processes moving forward.

This Fractional Finance Team offering seeks to provide a holistic solution to your organisation’s financial needs.

5. Financial Advisory Services
As we partner with Enzyme for a long term scope we have also seen an appetite for advisory services to be an important part of our product offering. R3gen is pleased to offer financial advisory support to advance the Enzyme protocol development, analysis of relevant data to support projects and access to r3gen’s network of web3 contacts to support growth endeavours.

What does it cost?
We are excited to explore a long term relationship with Enzyme, our pricing is outlined below.

As we are keen to be long term aligned with the success of Enzyme we would propose to take our entire fee in $MLN paid at the spot price at the point of payment, as was the case during our first engagement phase.

To further evidence our desire for a symbiotic partnership we propose to take 20% of our fee as a MLN denominated fee vested 6 months from the date of invoice; further encouraging positive contributions to the protocol.

Fractional Finance Team - USD Denominated Fee: $9,320 USD/month to be paid in $MLN using spot price at point of payment
Fractional Finance Team - MLN Denominated Fee: 115 $MLN/month

Monthly Total: $9,320 USD
Monthly Vested Contract Total: 115 $MLN

We look forward to continuing to work with the Enzyme Council and being able to contribute to the success and growth of the protocol.

This MFP is to cover a period of 12 months, totalling $111,840 in liquid payment paid monthly and 1,380 MLN through vested terms.

Executive Summary ⚜️

Avantgarde has researched some PR options for the Council and recommends engaging Antidote Communications to help firmly position Enzyme as the industry’s leading on-chain asset management protocol.

The objective of this PR campaign is to enhance the reputation, visibility and awareness of Enzyme and Avantgarde by building relationships with key stakeholders, including the media, industry analysts, customers, and the general public. Our goal is to shape and manage the public perception of Enzyme and Avantgarde via the products and services we offer.

Given the ongoing bear market, most protocols are slashing budgets and reducing spend. As such, we feel there is a unique and strategic opportunity to make our voice heard and ensure that Enzyme gains ground on its competitors at a time of uncertainty.

We are seeking $45,900.00 in MLN tokens to fund 6 months of PR activities. Please see “Funding Requirements” for a full breakdown of costs.

What value does PR provide? 🧠💡

PR provides value by increasing brand awareness, establishing credibility and trust, and positioning Enzyme/Avantgarde as thought leaders in the TradFi and DeFi industries. By investing in PR and leveraging an external agency’s support, we can gain valuable insights into public perception and opinion, which can also inform business strategy and decision making.

Moreover, this will help Avantgarde start conversations with warm, relevant leads that are looking to allocate money into on-chain DeFi strategies. This has a direct and measurable impact on Enzyme’s AUM, as well as raising Enzyme’s profile as the premier on-chain asset management destination for both crypto-natives and traditional finance players.

Selecting The Right PR Agency ✅

After careful consideration and research, Avantgarde identified and commissioned five PR agencies / freelancers to pitch for the project.

YAP Global
Zebu Digital
Mike Ermolaev
Paradox PR
Antidote Communications

Each provider was asked to provide a detailed proposal outlining their approach, specific tactics and strategies, and costs associated with their services. Below is a snapshot of the main takeaways from each proposal.

Antidote Communications (Traditional PR)

• Cost = $7,050 p/m (includes content creation) plus an additional, one-off fee of $3,600 for the messaging workshop
• Deliverables = 6-8 deliverables

Strategy

• Create a consistent voice for Avantgarde and Enzyme
• Build a higher profile for the business, amongst your target audiences
• Directly reach audiences, to support commercial growth objectives
• Define your messages and tone of voice for both of your services, aligned to core target audiences
• Deliver an insightful, data-led PR programme, focussed on thought-leadership
• Utilise and stretch our PR activity, via a LinkedIn content and engagement programme

YAP Global (Traditional PR)

Cost = $9,000 p/m
Deliverables = 2 placements p/m (one long-form, one short-form)
Strategy = YAP uses a traditional PR strategy to earn placements with publications. This is achieved organically through media relationships and by pitching Enzyme as a thought leader on a specific topic. More manual work required to build relationships organically and earn trust in Enzyme as a source of news, thought leadership and expert opinion.

Zebu Digital (Paid Placements)

Cost = $11,000 every 8 weeks ($8,000 per PR placement package + $3,000 for content creation)
Deliverables = 5-6 placements per 8 weeks
Strategy = Zebu uses a content distribution model to secure paid placements with various publications. These are guaranteed placements for a set fee. More automated approach based on a transactional exchange, rather than positioning Enzyme as a thought leader.

Mike Ermolaev (Option 1 – Paid Placements)

Cost = $8,800 p/m (includes content creation)
Deliverables = 5 placements p/m
Strategy = Mike will use a content distribution model to secure paid placements with various publications. These are guaranteed placements for a set fee. More automated approach based on a transactional exchange, rather than positioning Enzyme as a thought leader.

Mike Ermolaev (Option 2 – Traditional PR)

Cost = $9,000 estimated ($1,000 per media partner + $1,500 pitching to review platforms + $TBC fee for content creation)
Deliverables = 3-5 placements p/m
Strategy = Mike will use a traditional PR strategy to form a pool of media partners to distribute press releases and place thought leadership articles. He will secure free reviews of Enzyme from a network of 350+ review websites. He will place thought leadership articles in media outlets by pitching ideas.

Paradox PR (Traditional PR)

Cost = $8,500 p/m (includes content creation)
Deliverables = 3 placements minimum p/m
Strategy = Solidify and grow the brand awareness of Avantgarde/Enzyme in national media, including outlets such as The New York Times, Reuters, and BBC. Establish a footprint for Avantgarde/Enzyme in financial media, including outlets such as Bloomberg, CNBC, and American Banker. Cement Avantgarde/Enzyme's reputation as an industry leader in DeFi, including outlets such as CoinDesk, Cointelegraph, and Crypto Daily.

We have reviewed each proposal, taking into account factors such as the agency's experience and expertise in the crypto, asset management, and DeFi space, the proposed tactics and strategies, and of course the costs associated with each proposal.

Our final selection of Antidote Communications is based on the agency's ability to deliver on our objectives within a reasonable cost per month.

What monthly PR objectives will we achieve? 🚀

Monthly objectives for PR will be specific, measurable, achievable, relevant, and time-bound (SMART). Here are the specific monthly deliverables that we have agreed with Antidote Communications.

Messaging (kick-off)

• Messaging workshop
• Messaging house / TOV document produced
• Ongoing monthly sessions to review key messages

2x “Press-Office” secured p/m

• Senior appointments
• Industry commentary
• Jumping on news agenda
• Hot topics
• By-line articles
• New client wins
• Press release

2x “Thought Leadership” secured p/m

• Feature articles – promote our thinking to relevant media outlets
• 2x Articles adapted for social platforms p/m
• Turn feature thought leadership articles into content for Medium, Twitter and/or LinkedIn

1x Monthly LinkedIn Newsletter

• A monthly LinkedIn newsletter, repurposing an existing piece of content that we have placed in the media. This will be issued to all of your LinkedIn followers to drive engagement.

2x Speaker/Event opps secured p/q

• Conference speaking opportunities (panels + keynotes)
• Podcast interviews

What media publications will we target? 💻

Media outlets targeting will be specific and relevant to the crypto, asset management, TradFi and DeFi space. Some examples of publications that cover these topics include:

• Bankless
• BeInCrypto
• Bloomberg
• BBC
• Blockworks
• Business Insider
• CoinDesk
• CoinTelegraph
• CNBC
• Crypto Briefing
• Crypto News
• Cryptoslate
• Decrypt
• Funds Europe
• Institutional Asset Manager
• Institutioal Asset Investor
• Investment Week
• The Times
• The Telegraph
• The Economist WSJ
• Financial Times
• The Block
• The Defiant

Each of the deliverables outlined in the previous “Objectives” section will be secured in these types of publications.

How do we measure ongoing performance? 🎯

Deliverable Metrics

• Is Antidote meeting the minimum monthly deliverables requirements?

Commercial Metrics

• Contribution to brand awareness
• Click-throughs from PR and social activation
• Increase in warm leads / closed sales that drive increase in Enzyme’s AUM

Editorial Output Metrics

• Reach and frequency amongst key audiences
• Presence of key assets in editorial: impact measures % brand mention,
• Message delivery: against Implicit / explicit delivery of brand values

Social Media Metrics

• Proactive content on influencer channels
• Engagement and advocacy metrics In owned and influencer channels
• Clicks through to PR and social generated content commercial traffic metrics

What would success look like in 6-12 months from now? 💪

Success in 6-12 months from now would mean that Enzyme and Avantgarde has established itself as a leader in the crypto asset management space through effective PR efforts. Specifically, success would be demonstrated by achieving the following:

1. Consistently securing coverage in top-tier industry publications and being recognized as a go-to source for expert commentary and analysis on crypto, asset management, and DeFi topics.
2. A significant increase in website traffic and social media engagement, indicating a strong online presence and visibility.
3. A substantial increase in brand recognition and reputation among key stakeholders, including investors, customers, media, and industry analysts.
4. Securing multiple speaking opportunities for company representatives at industry conferences and events, establishing Enzyme and Avantgarde as a thought leader in the space.
5. Building and maintaining relationships with key industry analysts and influencers, ensuring Enzyme and Avantgarde is well-positioned to stay on top of industry trends and changes.
6. Avantgarde securing business (eg. asset management) directly linked to our PR activities that brings AUM valued at a minimum of $5m to Enzyme

Funding Requirements 💰

Avantgarde is seeking a grant in the amount of $45,900.00 in MLN tokens. This figure enables us to engage Antidote Communications for an initial period of 6-months, after which activity will be reviewed and assessed to determine whether we will continue.

Funding requirements are broken down as follows:

Messaging workshop: $3,600 (one-time fee)
Antidote's monthly retainer: $7,050 p/m

$3,600 + ($7,050 x 6) = $45,900

Timeline 🗓️

Our first 90 days of activity would look as follows.

Month 1

• Review collateral Messaging workshop
• Campaign timeline
• Source data & case studies
• Research media list
• Hot topics for biz profiling
• Draft materials for profiling
• Media training
• Interview case studies

Month 2

• Business profiling and media relations
• Briefing notes for interviews
• Attending interviews
• Operational data mining
• And/or commission research
• Data analysis
• Ensure all deliverables are met

Month 3

• Create horizon scanning doc to identify trends
• Draft data story press materials
• Create data visualisation
• Issue data story to media
• Media relations Collate coverage
• Ensure all deliverables are met

Conclusion 💫

We are excited about the prospect of engaging Antidote Communications to lead Enzyme’s PR efforts. This will position Enzyme and Avantgarde as leaders in the space, raise awareness, connect us with warm leads, grow AUM and position us nicely as we move into the next bull market.

Thanks,

Conor Gilmore
Marketing Lead at Avantgarde

Email: [email protected]
Telegram/Twitter: @TheKidCG

What We Are Asking For

We are approaching the Enzyme Council with a funding request of 1,750 Euros to sponsor participation in the upcoming Crypto Assets Conference taking place in Frankfurt on the 17th of October, 2023.

The funds will guarantee Enzyme a distinguished speaking slot in the main auditorium, which will be both live-streamed and recorded, ensuring optimal visibility. This conference is a prestigious convergence of both the crypto world and the traditional finance crowd. By partaking, we hope to bridge the gap and introduce the vast potential of on-chain asset management (ie. Enzyme) to legacy institutions.

Why Should You Approve This Grant Request?

Enzyme's inclusion at the Crypto Assets Conference places it at the forefront of financial transformation. In this speaking slot, we will be sharing the stage with Sygnum Bank and Multichain Asset Managers Association (MAMA). Sygnum will be discussing its proof-of-concept vault on Enzyme, while MAMA will discuss its DeFight Investment Club on Enzyme. We will then have a unique opportunity to present the benefits of Enzyme’s institutional-grade DeFi offering to a room full of respected financial institutions.

The synergies between Enzyme, Sygnum Bank and MAMA are emblematic of the direction finance is heading. By securing this speaking opportunity, we can demonstrate to heavyweights of traditional finance the tangible results and benefits of Enzyme's platform, driving more institutional users towards on-chain asset management.

Benefits of This Opportunity

Influence & Positioning: With Enzyme being on the same platform as Sygnum Bank and MAMA, our voice will carry weight, cementing our position in on-chain asset management.

Outreach: The combined physical and online attendance guarantees wide exposure, making this an invaluable marketing opportunity.

Networking: The inclusive dinner and 2-day event pass for Luca Mossini provides a direct touchpoint with industry leaders, opening doors for future collaborations and partnerships.

More Info About the Crypto Assets Conference

Held in the bustling financial hub of Frankfurt, the Crypto Assets Conference is a significant event attracting over 450 on-site attendees and 4,000+ online viewers. With a speaker lineup of over 120 industry influencers and 25+ company booths, it's a testament to the evolving financial ecosystem.

Prominent attendees include top-tier institutions like BNP Paribas, Deutsche Bank, Goldman Sachs, UBS, Moody's, BNY Mellon, SocGen FORGE, Fidelity Digital Assets, Union Investment, Circle, and many more.

These institutions' curiosity and engagement with the crypto landscape signal an undeniable shift in the financial industry. More details can be found on their official website: https://crypto-assets-conference.de/

Funding Breakdown

The total amount of 1,750 Euros will be utilised as follows:

• A prime speaker slot in collaboration with MAMA and Sygnum Bank, which includes live streaming and recording.

• A networking dinner, allowing for one-on-one interactions with industry leaders.

• A 2-day event pass for our representative, Luca Mossini, ensuring continuous engagement throughout the conference.

Conclusion

Sponsoring this event is not just about the immediate visibility but about strategically placing Enzyme in a setting where legacy and the future of finance merge. It's a statement that Enzyme isn't just a player in on-chain asset management, but a leader pushing the boundaries.

For any further details or clarifications, please don't hesitate to get in touch.

Contact Info

Conor Gilmore
Head of Marketing at Avantgarde

Email: [email protected]
Telegram/Twitter: @TheKidCG

• Proposal

  • Build a yield source for PoolTogether that integrates with specially curated Enzyme vaults.

• Motivation

  • PoolTogether is at ~200M in TVL (https://defillama.com/protocol/pooltogether)
  • PoolTogether made it possible to integrate any protocol that can serve as a yield source (https://github.com/pooltogether/yield-source-interface)
  • Each yield source requires a new contract that has to be built, audited, deployed and maintained (one for Compound, one for Aave etc) -- making it costly and time consuming
  • Hence the case for meta-strategies as yield sources: where yield sources can be actively managed to achieve the best result
  • Yearn has been building a yield source for their v2 vaults (https://github.com/pooltogether/pooltogether-yearnv2-yield-source)
  • Enzyme’s vaults can be a flexible and more profitable alternative as a meta-strategy for PoolTogether depositors:
    • From WETH to Lido Curve staking
    • From DAI to aDAI Curve staking
    • From one token on Aave to Compound or Idle according to the best yield available
  • If Enzyme’s vaults become popular as a yield source this would increase the total AUM of the Enzyme protocol, ultimately benefiting MLN holders

• Implementation

• Why me?

  • Already working at the intersection of Enzyme and PoolTogether (thanks to #9)
  • Ex CTO of multis.co (crypto wallet for companies, eFounders, Y Combinator S19)
    • https://multis.co/
  • Fullstack engineer from Solidity to CSS with 10 year experience
    • https://www.linkedin.com/in/teawaterwire/
  • User and evangelist of PoolTogether since v1 (now v3)
    • https://twitter.com/teawaterwire/status/1232794151495897090
  • Active user of Enzyme through the fund "La Crypto C'est Rigolo"
    • https://teawaterwire.medium.com/la-crypto-cest-rigolo-d3e8f224044a

• Code wise

  • Making PoolTogether able to use Enzyme vaults as yield sources boils down to deploying contracts supporting the YieldSource interface (provided by PoolTogether).
  • Two contracts have to be built:
    • The factory contract that deploys new instances of yield sources (one token, one vault)
    • The EnzymeVaultYieldSource.sol that includes the logic and methods from the interface
  • The three main methods of this contract are “deposit”, “balance” and “redeem”.
  • Deposit
    • The PoolTogether prize pool will send tokens to the Enzyme yield source contract
    • The contract will buy shares of the corresponding vault and do some internal accounting to keep track of this deposit from that particular prize pool
  • Balance
    • The contract needs to compute and return the balance in underlying tokens of a particular prize pool
    • This will require for a vault to get the share value in denominated token
  • Redeem
    • The contract will burn shares of the Vault and get corresponding assets
    • The contract will have to swap these assets to the vault’s denominated token
    • And send to the prize pool the amount
  • The objective is to make a github repository similar to the one made by Yearn or Aave for the specific Yield Source implementations. With the usual tests and deploy scripts.

• Operations

  • The vaults that will be used by these yield source contracts require specific parameters:
    • No management fees (to avoid edge cases with negative yields)
    • Only yield positions (going up, or way up)
    • Could be operated by an admin, a multisig or a DAO

• Compensation

  • I estimate a complete solution requiring between 8 to 16 days
    • Including the first step that is a poc to evaluate feasibility (~ 4 days)
  • With necessary back and forth these won’t be consecutive days
  • I suggest invoicing on a half day basis for about $400
  • And sending monthly invoices in case it takes longer (no consecutive days)
  • Payment in MLN tokens at the time of transaction would be perfect

Description of the project

• MCI is a company that offers a variety of crypto indexes to investors, designed to maximize returns over a 3 to 5-year time horizon based on the investor's risk appetite.
• MCI's range of crypto indexes caters to different risk profiles, with options ranging from conservative to aggressive. Additionally, MCI offers investment opportunities into trends, like the Metaverse, Defi, Smart contracts, etc. Investors choose the index that best aligns with their investment goals and risk appetite.
• MCI aims to reduce the friction for onboarding crypto novices to decentralized index funds by offering simple solutions for non-custodial wallets and fiat on-ramps. By completing the tasks outlined below, MCI can help build a more scalable solution for users to deploy capital and invest in web3.

Scope of Work

• Asset Management Infrastructure
  • Tool for auto-deployment and rebalancing.
  • UI
• Application & engineering development (see product milestones).
• Product Expansion, debit cards, off-ramp, and insurance.

Synergies/benefits to the Enzyme ecosystem

• By building on the Enzyme ecosystem, we can increase the usage and adoption of the Enzyme protocol while providing our users with enhanced functionality, security, and experience. Enzyme will also be able to leverage our team's existing infrastructure, tools, resources, and knowledge to help increase Enzyme's market share/competitive advantage.
• As our product gains traction, we expect it will bring more users and AUM to the enzyme protocol.
• We plan to add more products, such as insurance, loans, and interest accounts, using Enzyme, making the MLN token more valuable.
• We plan to study Enzymes smart contracts more and will contribute to your technical development by reporting bugs, suggesting improvements, and lending our technical skills when possible.
• We plan to advertise Enzyme on our website as a partner.
• Explore opportunities to build on-chain compliance tools for Enzyme that meet traditional financial services regulatory reporting requirements making the product more appealing to institutional asset managers. (Sanctions, Transaction Monitoring, Travel Rule, KYC, etc).
• MCI is committed to open-sourcing our entire platform in the future allowing enzyme users and vault managers to leverage our code.

Token Use
Product development and protocol improvements

Product Milestones & Timelines
Quarter 1, 2023 (completed all milestones)
- Launch CCI Vault.
- Launch MVP in Ethereum.
- Launch marketing website
- Integrate fiat on-ramp via credit cards, bank accounts, google, and apple pay.
- Integrate Magic login.
- Integrate Gmail login.
- Launch light/dark mode themes.
- Launch news feed.
- Integrate Polygon into the application.

Quarter 2, 2023
- Integrate Mix Panel Analytics (4 weeks).
- Create detail/brand pages and fact sheets for each index (4 weeks).
- Update Magic modals using MCI designs and improve UX (6 weeks).
- Improve portfolio/Overview pages (8 weeks).
- Launch Defi and Metaverse Vaults (3 weeks).

Quarter 3, 2023
- Launch test version of the mobile app (12 weeks).
- Build and launch auto balancer (8 weeks).
- Integrate fiat off-ramp (12 weeks).

Quarter 4, 2023
- Launch debit card payment infrastructure MVP (16 weeks).
- Sanctions Compliance Vault Parameter Smart Contract Module (20 Weeks).
- Build admin application MVP (12 weeks).
- Launch mobile app V1 (8 weeks).

Quarter 1, 2024
- Launch MVP insurance coverage on assets (12 weeks).
- Launch admin application V1 (8 weeks).
- Launch Debit card solution V1 (8 weeks).

Funding Needs

• Depending on agreed-upon milestones, this will require $250k - $750k cash or equivalent in MLN.
  • Funding Schedule Options
    • Lump Sum or
    • Initial funding and fund disbursements at milestone completions.
• As an indication of our long-term commitment to Enzyme, MCI will partner with private investors to cover funding gaps. MCI is committed to working with the Melon Council in selling any significant amount of MLN tokens necessary to finance this project OTC, thereby reducing the volatility and increasing the legitimacy of the MLN token.

Working MVP
www.mycryptoindex.io

Team presentation
Pitch (Seed Round - April/May 2023)

Contact information
[email protected]

Github
https://github.com/My-Crypto-Index

What we are asking for

Avantgarde is writing to request a grant of $7,500 to sponsor, attend and speak at the upcoming Global Investment Forum in Geneva on June 15-16, 2023. We believe that attending this event is an excellent opportunity to showcase the potential of the Enzyme protocol, and to engage with key stakeholders in the traditional finance space that are interested in on-chain asset management opportunities.

We propose to host two sessions at the Global Investment Forum that will explore the emerging trends and investment opportunities in DeFi, blockchain and asset management.

Event 1: New Asset Management Opportunities in DeFi (Breakfast Session)

The world of DeFi has exploded in recent years, and with that comes new opportunities for asset management. This breakfast session will explore the various ways that high net-worth individuals, family offices, sovereign wealth funds, and institutional investors can safely and compliantly access these opportunities. Our team will share insights into the DeFi landscape, explore key trends and developments, and discuss the investment potential of this rapidly growing market. At the centre of this conversation will be the Enzyme protocol – as it provides the infrastructure and technology for on-chain asset management.

Event 2: The Future of DeFi: A Conversation with Mona El Isa (Stage Session)

As one of the leading trailblazers in the DeFi space, Mona El Isa is uniquely positioned to offer insights into the future of this market. This stage session will feature Mona in conversation with a moderator, who will ask a range of questions about DeFi and how Enzyme and Avantgarde are positioned to help investors safely and easily access DeFi investment opportunities. This conversation will explore key themes such as DeFi adoption, the potential for decentralized finance to disrupt traditional financial services and the future of on-chain asset management protocols like Enzyme.

Why should you approve this grant request?

The Global Investment Forum is widely considered to be one of the most prestigious and high-profile events in the investment world. The forum attracts a global audience of senior investment professionals, including institutional investors, hedge funds, private equity firms, family offices, and high net-worth individuals.

The event provides a platform for thought leaders, experts, and industry insiders to discuss emerging trends, share insights, and explore new investment opportunities.

Attending and speaking at such an event can offer significant networking and business development opportunities, as well as enhance the reputation and visibility of both individual speakers and the companies they represent.

Here are the benefits that we believe the Forum will offer us.

1. Exposure to potential investors
Attending the Global Investment Forum provides a valuable opportunity for Avantgarde to showcase the Enzyme protocol to potential investors, including high net-worth individuals, family offices, sovereign wealth funds, and institutional investors. This exposure could help attract new investors to the Enzyme ecosystem, ultimately contributing to the growth of the protocol.

2. Demonstrating expertise
By speaking at the event and participating in sessions on emerging trends and investment opportunities in DeFi, blockchain, and asset management, Avantgarde and Enzyme can position themselves as thought leaders in the space. This can help establish credibility for the Enzyme protocol and attract interest from potential investors.

3. Networking and collaboration
The Global Investment Forum provides an opportunity for Avantgarde to network with other industry players, including potential collaborators or partners. This could help the Enzyme ecosystem forge valuable relationships that could contribute to the protocol's growth in the long run.

4. Increased visibility and brand awareness
Attending the event and speaking on stage could increase visibility for the Enzyme protocol and raise awareness among a wider audience. This could help attract new users and contributors to the protocol, ultimately leading to its growth and success.

More info about the Global Investment Forum

The seventh edition of the Global Investment Forum will be held on the 15th and 16th of June in Geneva, Switzerland, at Hotel Intercontinental. The Forum is an exclusive invitation-only event bringing together thought-leaders from the business, academic and political sectors to discuss the major challenges faced at a global and regional level as well as solutions and opportunities ahead.

Titled New World, New Choices, the program will address rising environmental, social, geopolitical and economic tensions leading to a context of massive uncertainty, instability, as well as volatility. The pace at which the world is changing is unprecedented: the way we live, work, and relate to one another as individuals and communities is indeed evolving as fast as our adoption of disruptive technologies, now fusing physical, digital, and biological universes.

Recognizing that private investors and the private investment industry play an important role in supporting innovative strategies needed to solve these challenges, the 2023 forum will focus on the tools, skills and strategies that will allow us to collectively build resilience, guiding investment decisions towards collective prosperity and ultimately contributing to making better choices.

This year's speakers include:

François Hollande, Former President of France
Sa’ad Shah, Co-Founder and Managing Partner of Noetic

Costs and sponsorship package

The $7,500 sponsorship fee includes the following deliverables:

• Breakfast event hosted by Enzyme/Avantgarde on the morning of Friday the 16th
• Mona speaking on stage on Friday the 16th – exact timing and format to be agreed upon together
• Verbal mention of company name on podium during event and logo on GIF stage from host
• Mention in press release (if we do one), GIF newsletters, and other external communication platforms such as social media. As well as featured on the GIF website.
• Access to photos, articles, and other media from the conference for use in social media
• 10 conference pass invitations in addition to passes for your team
• Recording of content from mainstage (we will edit it after the event and share on our socials)

Conclusion 💫

We are very excited about the prospect of sponsoring and speaking at this year's Global Investment forum. It's one of the premier events on the global calendar, and provides us with a unique opportunity to promote Enzyme and Avantgarde's value proposition to a network of highly influential decision-makers.

Thanks,

Conor Gilmore
Marketing Lead at Avantgarde

Email: [email protected]
Telegram/Twitter: @TheKidCG

Moving this from a PR to an issue...

MFP: External Strategy- Automated AMM LP Staking

Proposal

External Position for AMM DEX Staking Rewards Auto-Compound

Description of the project

Exponent submits a funding proposal for External Strategy, a modular approach to automate passive strategy on DeFi protocols utilizing external position on Enzyme’s Sulu framework. With External Strategy, vault managers can run complex DeFi interactions in one transaction, or even delegate the responsibility automate the strategy to a third party service provider. The first strategy will be to compound staking rewards on Sushiswap and Quickswap on Polygon blockchain, thus allowing all vaults to deploy their own Beefy Finance/ Autofarm-like liquidity mining strategies right on Enzyme without technical knowledge or operations overheads.

Motivation

With the release of Sulu, a promising feature for vault manager is external position, which allows a fund managers the flexibility to interact with DeFi protocols without the need for external price feeds or asset fungibility, ie. Uniswap V3 or Compound debt position. However, running a complex DeFi strategy requires multiple sequential smart contract interactions which is still very difficult to achieve in the current form.

Exponent aims to create a general architecture for complex DeFi interactions while utilizing Sulu’s native external position feature

Benefits to the Enzyme ecosystem includes:

• vault managers still maintain full custody of the assets, still working within Sulu’s security model.
• any vault manager on Enzyme can opt-in to an external strategy they may want to utilize and even configure the contract settings on the fly
• a scope for interaction required by external actor to act on behalf of the manager is limited only to automate which performs a single task as required in exchange for a bounty.
• external strategy can be quicker to roll out given the tight scope of application logic and interface
• significant gas savings compared to running the same transactions sequentially through enzyme integration adapters.
• external strategy can hold assets that aren’t available on Chainlink price feeds
• first community external position code contribution.

Scope of work

The following are the deliverables that Exponent commit to as part of the proposal:

1. Working external strategy contracts with modular contract architecture
2. UniversalParser: a generic parser for external position
3. ExternalStrategyProxy: a proxy contract strategy that cross-check for allowlist and delegate calls to a strategy lib for implementation
4. ExternalStrategyRegistry: allowlist for pre-approved external strategies
5. SushiStrategyLib: Sushiswap + Staking rewards strategy contract. Swap, provide liquidity and stake LP tokens in one atomic transaction.
6. QuickswapStrategyLib: Quickswap + Staking rewards strategy contract. Swap, provide liquidity and stake LP tokens in one atomic transaction.
7. Test suite for the set of contracts
8. End to end test with the live contracts on Polygon
9. TypeScript integration library to simplify the process of building transactions and calling the smart contract from client and server side application.
10. Everything will be published as public and open source license on Exponent’s official GitHub organization

Working Prototype

the first version of a successful transaction flow has already been completed on Polygon with a real vault instance, FRAX and FXS liquidity pair on Sushiswap with SUSHI token reward.

Fund deployment from vault and strategy execution
Enter() transaction hash

Automated task on behalf of the vault manager
Automate() transaction hash

Example UniversalParser contract:

Example SushiswapStrategyLib contract:

Timeline

the work is to be completed in the next 4 weeks

• working strategy transaction on Polygon (already completed)
• test suites
• code refactoring and clean up
• a TypeScript library developed

Technical Details

the source code for the deliverables and the technical details can be found here:

https://github.com/exponent-cx/external-strategy

Team

Exponent is on a mission to facilitate treasury deployment at scale for web3 orgs that won’t compromise on trust. It achieves this objective with productized treasury services that are curated, automated and risk mitigated. Exponent already has experience building on top of the Sulu architecture with the upcoming release of its treasury product: Fennec Stash.

Other considerations

there are additional development and infrastructure discussion that must be taken into consideration which are currently not included in the scope of work.

• What are the ways Exponent can roll out the external strategy to other Enzyme vault managers, safely and securely
• how Enzyme existing vault manager’s front end may integrate with Exponent’s external strategy
• if applicable, smart contract auditing required to be done before the contract can get real usage.
• if applicable, how to coordinate on new development of StrategyLib and how funding proposals can be structured for individual strategy.

Funding Required

1500 MLN vested on completion of the above deliverables under the scope of work.

Future Possibility

There are strong future candidates for future development work on external strategy. For instance:

• Client application: hosted front end for vault manager to interact with the external strategy
• Off-chain automate task scheduler: Exponent can trigger automate transaction on behalf of all registered Enzyme vault managers.
• a Diversified LP Staking Vault: an Enzyme vault with diversified exposure to different liquidity pools on Quickswap and Sushiswap with fully automated liquidity mining positions.

Contact Information

for any further questions, please contact:

✉️ [email protected]

or dm us on twitter at
@exponent_cx

Enzyme Vault Management Tool

Proposal

• Make the Enzyme Vault Management Tool more usable to aid vault managers in managing their portfolios.
• Write documentation for our npm package so that other applications can use the 3 functionalities from the Vault Management Tool.

Motivation

• Enzyme is the decentralized protocol for asset management. It allows anyone to create or invest in a cryptocurrency fund. Recently, development on Enzyme has focused on “assets” (with more to come with the Sulu update). However, there has not been as much growth on the “management” side.

• The lack of proper management features becomes evident if you look at the current vaults and their holdings on Enzyme. The majority of funds hold under ten assets, and the funds themselves are not diverse. Vault managers don’t want to carry many assets because it becomes increasingly hard to manage.

• Our solution is to build tools that allow vault managers to do more on Enzyme.

• The end goal of this project being that if we set the stage with the right instruments, we’ll end up with some rockstar vault managers that get many more regular users to buy shares in Enzyme vaults.

Code Wise

• Replace user private key input field with the implementation of metamask through a getSigner() function for transactions.

• Change the Rebalance portfolio function in EnzymeBot.ts to accept percentage instead of amount for tokens (L290 - L321)

  -  Add the percentage logic within (L293 - L295) in a for loop for all the rebalancing tokens
  - Logic: 
  - get the entire value of the portfolio in USDC or ETH
  - Multiply the percentage of the  portfolio value to get the USDC/ETH amount
  - Divide Eth amount by the asset value to get the amount of asset to rebalance.
  

• Move functionality to store multiple buy/sell limit functionality to the front end and track all active orders with browser state management.

Why us?

We are a team of 4 developers and have already built a prototype during the DeFi Summer hackathon.
(https://devpost.com/software/enzyme-auto-manager-bot)

What we plan to add, fix, change and test

• Upgrade the login feature to use wallet plugins (Metamask) rather than asking for the user’s private key

• Update the buy/sell limit feature to allow multiple limit orders

• Create a User interface to allow easier management of limit orders.

• Add a price limit on the UI, which, after executing, closes out on the UI.

• Edit the rebalance portfolio function to work with percentages instead of amounts.

• Perform tests on both Kovan and Mainnet networks. We will initially perform the Mainnet tests with a local fork.

• Clean up the code and refactor functions with proper comments to help maintain the codebase.

Operations

The user will still need to input their vault address, but the private key login will be gone and replaced with a connect wallet using metamask.

Funding/Compensation

• The remaining fixes and changes to the vault management tool will take 25 - 30 days.
• We suggest a funding of $6000 to be used for gas fees and testing on live mainnet. (This includes the DeFiSummer prize money so an additional $2000). We will set up a Gnosis safe for this purpose.
• Upon completion of the changes listed above and testing on a mainnet fork and mainnet itself, we will have a testing period with a few Enzyme vault managers. We can then decide what else should be added or fixed with some input from them if necessary. After this point, we suggest $8000 in MLN as compensation.

Grant Proposal to the Enzyme Council: Content Sponsorship for The Defiant

Introduction

The Defiant is a leading online platform that provides insights into the latest developments in decentralized finance (DeFi) to keep its audience informed and up-to-date. With 4.5 million page views, 1 million YouTube views, 500k podcast plays, and 6.5 million newsletter views in 2022, The Defiant is a popular and trusted source of information for the DeFi community.

In this grant proposal, I present a sponsorship package for The Defiant that includes advertising and content creation for Enzyme. The proposal aims to increase Enzyme's visibility in the DeFi ecosystem by advertising its DAO Treasury Management solutions to the DeFi community.

Funding Costs

Avantgarde is seeking a grant of $4,250 from the Enzyme Council to cover the costs of the sponsored post and advertising bundle detailed in the proposal below. This is for option 3.

This bundle includes a sponsored article on The Defiant, which will be featured on the home page for one week, with a pop-up banner on the homepage (7,500 views/impressions) and a square banner on the article page (60,000 views/impressions) for one week. Additionally, social media posts on Twitter (6,000 views/impressions) and Instagram (1,500 views/impressions) will be posted.

The original price of the bundle is $10,625.00, but as a special offer, The Defiant is offering Enzyme a 60% discounted price of $4,250.

Content & Advertising

The sponsored article will be focused on Enzyme's trustless solution for efficient DAO Treasury Management. DAOs face the challenge of managing their funds in a trustless manner. Enzyme offers a treasury management solution that enables DAOs to manage their funds efficiently while remaining completely trustless.

The article will highlight Enzyme's approach to protecting against the misappropriation of funds by building custom protections, rigorously auditing contracts, and carefully documenting processes. It will also emphasize Enzyme's custom policies and permissions, which enable DAOs to enforce rules and restrictions on managers' actions, such as protocols and assets they can interact with, the size of trades they can make, and automated stop loss to remove permissions from delegated managers if they incur a certain amount of slippage and/or trading loss.

The article will be written by Avantgarde's experienced writers and shared with The Defiant's extensive DeFi-focused audience. Additionally, Avantgarde's design team will create attractive and engaging advertisements showcasing our Treasury Management offering, which will run on the wider Defiant website in tandem with the sponsored article.

Conclusion

The proposed sponsorship package for The Defiant offers Enzyme an opportunity to reach a highly engaged DeFi audience with a targeted message about its trustless treasury management solution. The package will include a sponsored article, banners, and social media posts, which will provide valuable exposure for Enzyme's solution. This will help to increase Enzyme's visibility in the DeFi ecosystem.

I look forward to working with The Enzyme Council to bring this project to fruition.

Thanks,

Conor Gilmore
Marketing Lead at Avantgarde

Email: [email protected]
Telegram/Twitter: @TheKidCG

Increasing opportunities and requirements

There are a number of areas where the DAO requires more resources to support the commercial and strategic opportunities we are encountering and at the same time, a more automated administrative framework is required to enable financial reporting and other administrative tasks.

A proposal to engage an interim consultant for an initial period of 4 months to work on the following:

• Enabling and managing robust legal frameworks and processes for the DAO
• Automating financial management, reporting and administrative functions.
• Managing investor relations and other interested financial parties
• Building relationships with potential investments and M&A opportunities
• Interface and coordinate with Avantgarde Finance on commercial, ecosystem and asset manager initiatives.
• Updating and managing the ecosystem grant process

The proposal is to engage Dyfan Williams as the consultant. Dyfan has been an advisor to Avantgarde Finance for over 2 years, advising on a range of areas including strategy, finance and asset management. Previously, Dyfan built, acquired and operated a number of fintechs under public and private ownership, managing corporate development and corporate venturing functions. Dyfan is a CFA charter holder and holds a masters degree from the University of Oxford.

The role is estimated to be the equivalent of 3 days per week and remunerated at $9k per month.

Introduction
Atlantis World is building the Web3 social metaverse. We’re connecting social with Web3 (NFTs, DeFi + DAOs) and gaming inside of a lightweight virtual world that’s accessible to everybody.

We believe that existing metaverses set a high-cost barrier to entry and a hardware standard that doesn’t match up with global readiness due to a focus on 3d/immersive experience. We’re building Atlantis as a lightweight, 2d pixel metaverse that will run on any device in the web browser, from anywhere in the world!

We’re curating a fully fledged crypto economy of the metaverse starting with game experiences that plug into Web3 applications. You can even visit digital banks and unlock billions of dollars in liquidity for anything from savings accounts to borrowing, or freely exchange money and trade anything from financial instruments to NFT wearables and other digital goods / collectibles such as land.

We’ll build token gated cities for your favorite communities, starting with the founding partners of the Atlantis World ecosystem… Here, communities will be able to host virtual events powered by spatial video/audio calling, as well as NFT treasure hunts, voting in DAOs and using other Web3 applications. We’re also working hard to enable customizability features as well as building SDKs so that leading creators and developers can improve Atlantis World as a global collective. We’re building the user owned metaverse, so want to enable that as soon as possible.

We’re also working toward a planet positive future in collaboration with our users and community… which is why we’re planting a biodiverse, carbon capturing virtual forest inside of Atlantis.

Deliverables
Build an Enzyme Bank inside of Atlantis World so that users can browse and deposit funds on the protocol. The bank will be fully personalised to Enzyme branding and even feature NPCs who teach users about Enzyme and guide deposits in-game.

Milestones
Total $25k grant funding request
Designing Enzyme Bank building $10k (to be completed in Q1)
Integrating Enzyme inside of bank building $15k (to be completed in Q1)

Next Steps to explore with the Enzyme Finance community
Build a fully personalised, token gated clubhouse for MLN holders with audio calling / virtual events and other Web3 integrations like voting in Enzyme Council DAO in-game. It could also include a VIP lounge for leading depositors and vault managers.
Creating MMORPG-style Learn2Earn (incentivized learning) quests to onboard users into Enzyme + the wider DeFi ecosystem.
Enable fund creation and management (build and manage) on Enzyme inside of Atlantis.
Enabling network effects by rolling out gamified Enzyme products in Atlantis City and cities of other DeFi communities such as Yearn or Balancer to onboard more users who are already Web3 native.
Display Enzyme Network Monitor in the clubhouse.
Airdropping bank + token gated clubhouse to the Enzyme / MLN community.
Enzyme wearables and swag inside of Atlantis World.
Enzyme core contributors co-working space (token-gated with NFT/POAP/social token etc)
Other suggestions from the Enzyme community.

Team
CJ Hetherington - Co-Founder + Product Lead
CJ has been a digital rights activist since the age of 8, and a tech entrepreneur since the age of 10; when he tried to raise $600k for a virtual casino way ahead of the crypto economic infrastructure that exists today. CJ hacked together one of the first ever gamified yield farms last year, building in the NFT space when transaction volume was below $200k USD / day (continuing to grow at an unprecedented rate but currently over $200M).
https://www.linkedin.com/in/cjhweb3/

Rev Miller - Co-Founder + Growth Lead
Rev is a serial entrepreneur with over 8 years experience building and growing media, FinTech, 3D / XR, and Web3 networks. He’s also leading adoption at Witnet, the decentralized oracle network.
https://www.linkedin.com/in/revmiller/

Julio Alcantara - Lead Game Developer
Julio is our lead game developer who has an additional 6 years of experience in design. He’s currently overseeing core development of Atlantis World, whilst working across the tech stack from PhaserJS, UI/UX design and Web3 integrations, as well as even creating game assets. Julio led the Atlantis tech team to win Best DeFi Project on Polygon as well as prizes from Aave and Audius at HackFS, and a winning effort in NFT Vision Hack’s Rarible track. In the past, he’s also led teams and won hackathons at Mintbean.
https://www.linkedin.com/in/deadheadstudio/

Ilayda Pinarbasi - Lead Designer
Ilayda is our lead game designer with over 4 years of experience designing and even developing games. Whilst currently studying game design in Istanbul, she recently completed an exchange program at Seoul National Tech University in Korea. Also, Ilayda is a Youtube creator with over 500k views and enjoys Twitch streaming.
https://www.linkedin.com/in/ilaylay/

Rachit Srivastava - Blockchain Developer
Rachit has been programming in Java since age 13 and is a full stack blockchain developer. He loves to build/chat/research anything blockchain related, aiming to contribute to the ecosystem by building solutions, with a primary interest in DeFi. He’s also a solidity developer at Nethermind, as well as a contributor at Harmony.
https://www.linkedin.com/in/rachit-anand-srivastava-345307173/

Austyn Studdard - Game Developer
Austyn is an experienced game developer with over 5 years of experience, as well as being official developer support in the PhaserJS Discord server for over 2 years and making contributions to the core PhaserJS framework. He recently joined us from Treeverse, a sci-fi and fantasy based blockchain MMORPG.
https://www.linkedin.com/in/kingcosm1c/

Chris Diperio - Game Developer
Chris found his way into software development having almost fully automated his financial analysis role as an operations manager at Xerox using SQL and becoming restless. He then became proficient in Java, C++ and C# before being captivated by Javascript, eventually joining Atlantis World as a game developer. Chris is comfortable wearing many hats across our tech stack.
https://www.linkedin.com/in/christopherdipiero/

Carlo Migueldy - Web3 Developer
Carlo is a software craftsman from The Philippines. Over the past 3+ years, he’s worked across various tech stacks and recently made the jump to go full time in Web3. He’s a highly versatile and passionate engineer, known to make high quality and easily maintainable applications. In his spare time, he enjoys researching Web3, contributing to DAOs such as Developer DAO and writing technical documentation / creating tutorials.
https://github.com/carlomigueldy

External Links
Website: https://atlantis.world
Demo: https://atlantis-world-cryptopunk.netlify.app/ (confidential, we’ve intentionally closed down public demo access)
Discord: https://discord.gg/atlantisworld
Twitter: https://twitter.com/atlantis0x

Yearn announcement: https://twitter.com/iearnfinance/status/1432387438014435332
The Defiant featuring Yearn <> Atlantis + Aleksandr from Axie Infinity:
https://thedefiant.io/yearn-degens-metaverse/
Balancer Grants blog post:
https://medium.com/@BalancerGrants/atlantis-world-will-be-building-balancer-city-with-its-new-grant-ebb0c6755b20
Perpetual Protocol <> Atlantis World https://twitter.com/perpprotocol/status/1442836528594661382

Final Notes
We're currently building hard on a completely new version of Atlantis which we're planning to ship in Jan ‘22 On our first prototype / demo version we had over 2k active users, for the new version we have over 6k early access sign ups.

We're still fully bootstrapped, managing to scale our team to 8 full time core contributors on the back of grants, collabs + our own capital. So, the support of Enzyme would be huge to us in helping us build the user owned metaverse for public good whilst accelerating the adoption of both the Enzyme ecosystem and Web3 in general. In terms of user ownership, we want to enable that ASAP, though we’re exploring alternative methods vs launching a token as it stands right now.

Our current ecosystem partners have social media communities of 5M+ users that will be invited to beta test Atlantis and become our early adopters. Joint marketing is a core part of our GTM and we’re onboarding new partners at an unprecedented rate.

We also plan to enable network effects for all parties involved, by incentivising and encouraging different partner communities to try each other's products inside of Atlantis. As well as this, we’ll also target non crypto natives with interactive learning for DeFi and other Web3 building blocks like DAOs, blockchain games and blockchain wallets, even creating core Web3 onboarding and wallet creation experience.

We also have super active 7k+ Discord users, with 6k+ mobilising to make a contribution to our Gitcoin grant.

Proposal

Implementation of an affiliate and/or referral program for the Enzyme protocol.

Description of the project:

It would build on top of the first analysis done following the initial proposal by Mona and Luca.
See ENZIP 13 (enzymefinance/enzip#13 (comment))

Several milestones would need to be reached:

1. finalization of the conceptual design of the program(s)
   • terms & conditions: payouts, eligibility, etc.
   • metrics
2. governance vote on programs & their design
3. implementation plan laid out
   • UX, workflows
   • communication plan
   • marketing material (eg. FAQ)
4. monitoring & reporting is in place
   • dashboard
5. technical modification implemented → go live

Optional (i.e. maintenance mode):
6. (manual) onboarding of affiliates/partners
7. regular reviews take place
8. issue final review at program’s end with recommendations

Out of scope: no dev work is included in this funding proposal.
The goal is to minimize the involvement of the engineering resources.
But it will depend on the level of automation/integration selected.

Synergies/benefits to the Enzyme ecosystem

Mona and Luca of Avantgarde kicked off the discussion on the topic in September (cf link above).
With the massive product improvements in 2022 (Sulu, Polygon, etc.), the Enzyme protocol has a very solid basis from which to accelerate in its markets.
Enzyme has been relying for its growth on several traditional channels, such as brand development (online presence) or the BD efforts of Avantgarde, etc.
The protocol should now also explore the potential benefits of growth vectors such as affiliate/partner programs or referrals.

The benefit to the Enzyme ecosystem: growth (TVL and/or users, tbd)
The second-order benefit of letting me run this project? More time and mindspace for the Avantgarde team to focus on items of higher priorities (many of those atm)

The synergies? There are demonstrated results of using financial incentives to bring more people into one’s ecosystem; this will need some reflection & fine-tuning in order to not acquire growth at any cost.

Timeline:

• preliminary analysis self-initiated at the beginning of November
• the project will be run in a way as to minimize and facilitate the necessary decision-making, so that we can move and iterate fast
• nevertheless a few steps will depend on the feedback and support of people at the Council & at Avantgarde Tech, so that it makes it hard to commit to a clear timeline
• to use a range: in the best case, the program could go live within 2 months of the project start; adding some buffer to take into account friction and other unforeseen delays, 4 months until implementation; the project manager could be incentivized to launch the project as fast as possible if desirable

Funding needs:

Funding for the project management & coordination services (milestones 1 to 5):
MLN tokens (without vesting for these small amounts), milestones-based:

1. 650 MLN when the first program is submitted to a vote
2. 650 MLN when the first program is implemented
3. Bonus fee of 650 MLN if the first program is implemented within 3 months of the council giving the green light to this MFP
4. for any work thereafter related to the programs (such as optional work as in steps 6 to 8 above): rewards with tokens at a monthly rate of 650 MLN pro-rata of the time spent

Team presentation:

• osaat: business professional with engineering background (non-dev), with extensive project management and sales experience; familiar with Enzyme since 2019; also active in the Nexus Mutual community; their team contracted me earlier this year for project management services to coordinate the launch of a new product, help structure their BD efforts and prepare the necessary steps for the launch of another long-term project.
• Project sponsor at the Enzyme technical council = Avantgarde Finance
• Referent person at Avantgarde Tech = Mona El Isa

Contact information:

TG: @ oSaaT2